KATHLEEN ROUSSEAU: Open Payments
NPI 1053783175 · WEST DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,330 in 51 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $708 · 2025 $1,330
Food & beverage: $1,330
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $293 |
| ABBVIE INC. | 15 | $249 |
| Otsuka America Pharmaceutical, Inc. | 4 | $185 |
| Janssen Pharmaceuticals, Inc | 1 | $150 |
| Vanda Pharmaceuticals Inc. | 4 | $112 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $65 |
| Axsome Therapeutics, Inc. | 2 | $45 |
| PFIZER INC. | 2 | $43 |
| Lilly USA, LLC | 1 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
Products named: CAPLYTA, VRAYLAR, REXULTI, SPRAVATO, FANAPT, TRINTELLIX, Auvelity, NURTEC ODT.
Industry payments across IA — which companies pay providers there.
